Ark Invest Tracker(@ArkkDaily):A PERSONALIZED CANCER VACCINE CUTS MELANOMA MORTALITY BY 50%. - Custom mRNA designed from your own tumor after surgery. Takes a couple of weeks to manufacture per patient. - Combined with Keytruda it reduces mortality by roughly 50% compared to Keytruda alone. - The COVID vaccine funding built the mRNA manufacturing infrastructure that made this possible.

Ark Invest Tracker

@ArkkDaily

Daily updates for Cathie Wood's Ark Invest fund. | Visit Ark Invest's official website below! | Not affiliated with Ark in any way.

Joined September 2020

326 Following 136.8K Followers

Ark Invest Tracker@ArkkDaily

2026.09.04 18:00

A PERSONALIZED CANCER VACCINE CUTS MELANOMA MORTALITY BY 50%. - Custom mRNA designed from your own tumor after surgery. Takes a couple of weeks to manufacture per patient. - Combined with Keytruda it reduces mortality by roughly 50% compared to Keytruda alone. - The COVID vaccine funding built the mRNA manufacturing infrastructure that made this possible.